pillbase.ru

ORSERDU

Active substance: elacestrant

TABLET, FILM COATED · ELACESTRANT 86 mg/1

United StatesActive

Marketing holder: Stemline Therapeutics, Inc.

Verified 2026-10-09 · openFDA NDC

Analogues in other countries
Composition
Analogues by country

Products with the same active substance registered in other countries.

CountryProducts
EU 1
  • Orserdu
    elacestrant
    EMEA/H/C/005898
    Stemline Therapeutics B.V.
Import and control

Control by country

  • United Statesprescription only

    Source: openFDA NDC · record 01a1208f-00a4-7957-95ec-c336384d7d46,01a1208f-00a8-79d3-a053-8fb593d61c7e;count=2 · valid from 2026-10-09 · verified 2026-10-09

More on control status
Registration
Registration number
72187-0101
Registration status
Active
Dispensing
Prescription only
Route
ORAL
Sources
  • product · openFDA NDC · 72187-0101 · Verified 2026-10-09 · open in source
  • registration_status · openFDA NDC · 72187-0101 · Verified 2026-10-09 · open in source
  • ingredients.0 · openFDA NDC · 72187-0101 · Verified 2026-10-09 · open in source